I have never owned Novelos, nor will I ever own Novelos. I hoped that it would have positive phase 3 results for the many NSCLC patients out there, but, sadly it didn't. It's not a scam just because the trial didn't work out, it's a scam b/c the company got BMR to pump this stock up to $3, and they're trying to get the price up now by claiming the lawsuit is w/o merit. The company has no drugs that will ever amount to anything, IMO. The HCV drug was just put in the P3 results PR b/c Novelos didn't want this to go down to <.10.
Nov-002 failed a pivotal trial in NSCLC, how can you think that the trial in breast cancer will be any different?
Also, if you bring up the russian trial results, almost every drug that has succesful results in a russian trial fails. Medivation was the latest victim.
The Novelos drug is just an anti-oxidant. If it works so well, then why isn't green tea a blockbuster?
News 
Market Data 
Discover 
AI
